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Mice with targeted disruption of the lama3 gene, which
encodes the a3 chain of laminin-5 (a3b3c2, 332), develop a
blistering skin disease similar to junctional epidermolysis
bullosa in humans. These animals also develop abnormalities
in glomerulogenesis. In both wild-type and mutant animals
(lama3/), podocytes secrete glomerular basement
membrane and develop foot processes. Endothelial cells
migrate into this scaffolding and secrete a layer of basement
membrane that fuses with the one formed by the podocyte.
In lama3/ animals, glomerular maturation arrests at this
stage. Endothelial cells do not attenuate, develop fenestrae,
or form typical lumens, and mesangial cells (MCs) were not
identified. LN a3 subunit (LAMA3) protein was identified in
the basement membrane adjacent to glomerular endothelial
cells (GEnCs) in normal rats and mice. In developing rat
glomeruli, the LAMA3 subunit was first detectable in the
early capillary loop stage, which corresponds to the stage at
which maturation arrest was observed in the mutant mice.
Lama3 mRNA and protein were identified in isolated rat and
mouse glomeruli and cultured rat GEnCs, but not MC. These
data document expression of LAMA3 in glomeruli and
support a critical role for it in GEnC differentiation.
Furthermore, LAMA3 chain expression and/or another
product of endothelial cells are required for MC migration
into the developing glomerulus.
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Laminin (LN) is a large heterotrimeric matrix glycoprotein
that regulates cell attachment, proliferation, and differentia-
tion.1,2 Temporal and spatial changes in LN isoform
expression occur as glomerulogenesis proceeds.3–5 In the
immature mouse glomerulus, LN-1 (111, a1b1g1) predomi-
nates.6 As the glomerulus matures, the LN a1 subunit
(LAMA1) is reduced and a5 (LAMA5) becomes the
predominant a chain detected in the glomerular basement
membrane (GBM).7–9 Conversion in expression of LN b1
(LAMB1) to b2 (LAMB2) in the GBM is associated with the
final stages of glomerular capillary wall formation.10 In the
mature glomerulus, podocytes predominantly synthesize LN-
11 (521, a5b2g1).11 A change in the isoform of collagen IV
temporally accompanies the transition in LN b chain
expression in the GBM; however, it is not dependent on
the expression of LAMB2. Ultimately, collagen IV composed
of a3, a4, and a5 chains predominate over a1 and a2 chains.
Although previously it was thought that the mature GBM
was produced only by podocytes, recent data show that
glomerular endothelial cell (GenC) continue to secrete
basement membrane in adults and that the endothelial side
of the GBM continues to contain collagen IV composed of a1
and a2 chains.12,13 The LN isoform synthesized by GEnC has
not been defined. In developing and adult humans, the
mesangium stains positively for the LN a4 subunit
(LAMA4).14 In mice, developing mesangial cells (MCs)
initially express an LN isoform containing LAMA4,15 with
subsequent appearance of LN a2 (LAMA2) and LAMA5.15,16
Thus, specific transitions in LN isoform expression occur
throughout the glomerulus as it matures.
The importance of LN isoform expression to the diffe-
rentiated phenotype and function of glomerular cells is
supported by a number of studies. When glomerulogenesis
occurs in a hyperglycemic and insulin-deficient environment
in rats analogous to diabetes, there is impaired switching of
LN b chain expression from LAMB1 to LAMB2, which is
associated with delayed MC differentiation.17 In lamb2 null-
mutant mice, glomerular epithelial and endothelial cells
develop normally; however, animals die shortly after birth
from severe nephrotic syndrome.3 This implies that an
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LAMB2-containing isoform of LN is critical for the main-
tenance of capillary wall integrity; yet, the mechanisms by
which the LAMB2 chain conveys this function are not known.
In humans, mutations in lamb2 are associated with
proteinuria and mesangial sclerosis.18 Mice that fail to express
LAMA519 have disordered glomerulogenesis. In these animals,
epithelial cells are in disarray, endothelial and MC cluster
outside of the developing glomerulus, and the capillary loops
fail to form. A specific role for LAMA5 in condensation of the
mesangial matrix that produces the mature, corrugated
structure of the capillary loops has been suggested by its
temporal appearance in the mesangium and in studies with
chimeric chains.20 In aggregate, these studies indicate that
critical transitions in LN isoform expression are required for
specific steps in cell differentiation during glomerulogenesis.21
LN-5 (332, a3b3g2) is the major adhesive ligand present in
the basement membrane of stratified epithelium.22 Mutations
in LN-5 disrupt cell–matrix attachments in skin and are
associated with junctional epidermolysis bullosa, a fatal
blistering skin disease in humans.23,24 A lama3 null-mutant
mouse was described that has abnormalities in survival and
late-stage differentiation of epithelial cells mimicking junc-
tional epidermolysis bullosa in humans.1 Because we had
identified lama3 mRNA in rat GEnC in culture, we
postulated that LAMA3 might play a role in GEnC
differentiation during glomerulogenesis. In this report, we
show novel changes in GEnC differentiation in mice with
targeted disruption of the lama3 gene. In association with
arrest in endothelial cell maturation, MC do not develop.
Complementary studies in rat kidney tissue and rat
glomerular cells in culture confirm that GEnC normally
express an LAMA3-containing LN isoform. Staining of
developing glomeruli show that the appearance of LAMA3
protein temporally correlates with the stage of maturation
arrest identified in the lama3/ mice. These data add to our
understanding of the critical role of LN isoforms in
glomerulogenesis, and provide additional evidence for the
interaction between endothelial cells and pericytes in final
differentiation of blood vessels (BVs).
RESULTS
Newborn mice
A detailed description of the phenotype, skin lesions, and
survival characteristics of lama3 null-mutant mice has been
reported previously.1 The surface contour of the kidneys,
ureters, and bladder appeared normal; thus, extensive
histological studies of the kidney were not undertaken.
Mutant pups have difficulty suckling because of skin fragility
and pyloric stenosis; thus, they become dehydrated shortly
after birth. Functional abnormalities were attributed to
dehydration. To avoid confounding acute renal failure, pups
were studied at birth.
Histological abnormalities
In the mouse, glomerulogenesis is not complete until
approximately 2 weeks after birth; thus, all stages of
glomerulogenesis can be identified in sections of normal
newborn kidney.4 In kidneys of wild-type mice, glomeruli
were abundant and demonstrated all stages of development,
including mesenchymal condensate, comma-shaped bodies,
s-shaped bodies, early capillary loop stage, and maturing and
fully mature glomeruli.25
Normally, at the capillary loop stage, GEnC line the GBM,
and secrete their own matrix, which fuses with the GBM
made by podocytes. Initially, GEnC fill the space created by
the loop of GBM. As they differentiate, GEnC attenuate,
thereby creating the lumen, and eventually develop fenestrae.
As GEnC differentiation nears completion, alpha-smooth
muscle actin (a-SMA)-positive MC appear in the central
zone of the glomerulus and begin to secrete their own matrix.
Coincident with detectable MC, the endothelial nuclei
become oriented on the side of the capillary loop adjacent
to the mesangium and GEnC proliferation slows. As the
GBM lengthens, it begins to convolute, creating multiple
capillary loops. In the final stages of glomerulogenesis, the
mesangial matrix condenses creating well-defined capillary
loops. These features of normal glomerulogenesis were
apparent in wild-type mice (Figure 1). Inspection of kidneys
in lama3/ mice revealed normal stages of glomerulogenesis
up to the early capillary loop stage. Fully mature glomeruli
were not observed in lama3/ mice. In lama3/ mice,
glomerular maturation arrested after angioblasts populated
the developing glomerulus. Lama3/ mice had few patent
loops and no apparent mesangium; rather, the central zone of
the glomerulus was filled with immature endothelial cells.
Normally, MC migrate into the central zone of the
developing glomerulus after GEnC. Initially the mesangial
matrix appears loose, but as it reorganizes, it becomes more
electron dense and condenses. As this occurs, each of the
capillary loops become more apparent. This change was easily
a b
c
Figure 1 | Electron micrographs of glomeruli from wild-type and
mutant mice. Shown in (a) is a normal glomerulus in a sample from a
lama3þ /þ mouse. Several capillary lumens (L) are noted and
endothelial cells (arrow) have nuclei oriented toward the central zone
of the loop. MC are present. Shown in (b) is a glomerulus from a
lama3/ mouse. One small lumen containing an erythrocyte (E) can
be seen, but otherwise the central zone is filled with endothelial cells.
In (c), a sample from a lama3/ mouse shows a glomerulus
delineated by Bowmans capsule (BC), but it is filled with
undifferentiated cells that lack structural landmarks.
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identified in kidneys from lama3þ /þ mice; yet, a central
mesangial zone or distinct MC were not identified in any
glomeruli in lama3/ mice. Furthermore, the corrugated
appearance of multiple capillary loops did not develop. In the
absence of MC, proliferating GEnC filled the central zone of
the developing glomeruli. The abundance of endothelial cells
and absence of MC was confirmed by biochemical markers
(see below). Thus, targeted disruption of the lama3 gene was
associated with maturation arrest of GEnC at the juncture
between early capillary loop formation and complete
maturation.
In some glomeruli (Figure 1c), the structure of
the glomerular tuft was lost. These glomeruli had a well-
developed Bowmans capsule with attenuated, mature appear-
ing parietal epithelium; nevertheless, the glomerular tuft was
a ball of undifferentiated cells, and no extracellular matrix
was present. Because this was only observed in glomeruli that
exhibited a mature Bowmans capsule, which occurs at the
capillary loop stage, it suggests that glomerular cells initially
developed to the degree seen in other glomeruli, but cellular
differentiation could not be maintained when the entire
structure failed to mature. For every 10 glomeruli that
reached the capillary loop stage, approximately one glomeru-
lus showed this morphology. No similar glomeruli were seen
in kidneys from wild-type mice. These changes are noted
schematically in Figure 2.
Details of glomerular cell differentiation are shown at
higher magnification in Figure 3. The basement membrane
secreted by podocytes in lama3/ mice had a normal
appearance, and podocytes had normal-appearing foot pro-
cesses (Figure 3a). GEnC were identified along the internal
surface of the basement membrane elaborated by podocytes.
GEnC also secreted a normal-appearing basement mem-
brane. In some capillary loop segments, basement mem-
branes from the podocytes and endothelial cells were distinct
and in other segments they had fused (Figure 3a), which
implies that the absence of LAMA3 in the GBM does not
prevent fusion of the products of podocytes and endothelial
cells. GEnC maturation was arrested at the early capillary
loop stage in lama3/ mice (Figure 3b). GEnC filled the
central zone, of the developing glomerulus, and their nuclei
remained large with loose chromatin. The endothelial cells
did not attenuate to form a widely patent lumen (Figure 3c).
In the most mature glomeruli, 1–3 capillary loops per
micrograph cross-section were present in contrast to the 4–6
loops usually seen in lama3þ /þ mice. Fenestrae were not
identified in endothelial cells of lama3/ mice, whereas
fenestrae were readily apparent in wild-type mice (Figure 3d).
Immunostaining for glomerular cell markers
To further assess glomerular development, tissues were
stained for cell markers. As podocytes begin to differentiate,
they express WT-1.26 As predicted by the presence of foot
processes, podocytes stained positively for WT-1 in
both wild-type and mutant mice (Figure 4a and d).
Undifferentiated angioblasts in the mesenchyme adjacent to
developing glomeruli do not have detectable vonWillebrand
factor (vWF); however, vWF is detectable coincident with the
identification of GEnC within the glomerular capillary loop.
Glomerular endothelial cells stained positively for vWF
in both lama3þ /þ and lama3/ animals (Figure 4b and
e). In wild-type mice, the staining corresponds to endothelial
cells associated with capillary loops and the central mesangial
zone is negative. In contrast, staining in lama3/ mice
showed bright staining throughout the central zone suggest-
ing that this space is filled with endothelial cells. As MC
migrate into the glomerulus,27 they express aSMA.28 aSMA is
also present in the muscular layer of arterioles and small
arteries within the kidney. At birth, MC continue to express
aSMA, although it diminishes as the animals mature, and
reappears in diseased glomeruli.29 In lama3þ /þ animals,
bright staining for aSMA is observed in arterioles and
glomeruli (Figure 4c). In contrast, aSMA staining is present
in arterioles, but not glomeruli of lama3/ mice (Figure 4f).
In models of angiogenesis, developing endothelial cells
secrete platelet-derived growth factor (PDGF), which serves
as a mitogen and chemoattractant for developing pericytes.30
Previous studies31,32 have shown that PDGF is required for
MC development. PDGF is present in normal developing
∗Capillary lumen
∗Capillary lumen
WT-1+ (GEC)
WT-1+ (GEC)
vWF+ (GEnC)
vWF+ (GEnC)
SMA+ (MC)
Parietal epithelium
Figure 2 | Schematic diagram of abnormalities in lama3/ mice.
These characteristics are shown schematically for (top panel) wild-
type and (middle and lower panels) mutant mice. The most common
appearance of glomeruli in lama3/ mice is shown in the middle
panel. A glomerulus containing a ball of undifferentiated cells is
shown in the lower panel. Also noted in these figures is the
expression of cell-specific markers. Podocytes (GEC) express WT-1,
GEnC express vWF, and MC express aSMA. Glomeruli in lama3/
mice lacked aSMA staining, and cells shown in the lower panel
stained negatively for all three markers. *Capillary lumen.
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glomeruli, detection is lost in mature glomeruli, and PDGF
becomes abundant again in certain diseases.33 Because of the
maturation arrest of endothelial cells and the absence of MC
in the lama3/ mice, we stained mouse kidneys for PDGF B
chain. As shown in Figure 5, newborn lama3þ /þ mice no
longer have detectable PDGF in glomeruli, although PDGF
staining was present in small arterioles. In contrast, abundant
PDGF was detected in glomeruli and arterioles of lama3/
mice. These observations indicate that GEnC develop to the
stage of PDGF expression, but fail to mature to the stage
where PDGF expression declines. Also, lack of PDGF is not
the reason for lack of MC. In models of angiogenesis, pericyte
recruitment to the developing tube of endothelial cells leads
to a reduction in endothelial cell proliferation and PDGF
expression, and final maturation of the endothelial cell;34
thus, MC may be required to promote these final steps in
GEnC maturation. Furthermore, these data imply that an
undefined factor(s) in addition to PDGF is required for MC
development.
LN chain and collagen expression
LN and collagen IV isoform expression differs in the GBM
and mesangial matrix, and it changes with glomerular
development;7,8,11,35 thus, we wondered if the morphologic
changes observed in the lama3/ mice were associated with
other changes in LN or collagen IV isoform expression.
Staining with antibodies to LN-1 appeared similar in
lama3þ /þ and lama3/ mice (Figure 6a and g), except
that glomerular staining was amorphous and did not identify
a distinct mesangial zone in lama3/ mice. LAMA5 (Figure
6b and h) was detected in GBM, tubular basement membrane
(TBM), and in a mesangial pattern in lama3þ /þ mice.
Although LAMA5 was present in the GBM of lama3/, none
was observed in the central mesangial zone. As LAMA5
appears in the mesangium as the capillary loops mature, this
change in pattern is consistent with the absence of MC. As
the LN g1 chain (LAMC1) is present in all of the glomerular
isoforms of LN, the pattern of staining for this chain was
similar in the two groups of mice (Figure 6c and i). In normal
glomerulogenesis, LAMB1 is initially present in the GBM,
where it is replaced by LAMB2 as endothelial cells appear,
and it appears in the mesangium coincident with population
of the glomerulus with MC. This transition occurred in
lama3þ /þ mice; however, in lama3/ mice, LAMB1
persisted in the GBM and did not become concentrated in
–/– –/–
–/–
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c
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Figure 3 | Electron micrograph of capillary wall. High-power
electron micrographs from (a–c) lama3/ mice and (d) lama3þ /þ
mice. Shown in (a) is a peripheral capillary loop with differentiated
podocytes with normal-appearing foot processes (FP). Basement
membrane products of podocytes and GEnC are shown unfused
(arrowheads) and fused (arrows). A single capillary loop is shown in
(b) that is filled by an immature endothelial cell (GEnC). The GBM is
entirely fused, yet the endothelial cell appears immature, and is not
attenuated. (c) In another glomerulus, a loop is shown where the
endothelial cell fills the space interior to the GBM and only a small
lumen is present (L). Note that endothelial cells are not attenuated
and no fenestrae are seen in a, b, or c. In (d), attenuated endothelial
cells with fenestrae are seen as a cross-section perpendicular to the
GBM (arrows), as well as cut tangentially (arrowheads) in a sample
from a wild-type mouse.
(+/+) (–/–)
WT-1
vWF
SMA
a
b
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Figure 4 | Immunofluorescence staining of lama3þ /þ and
lama3/ animals. Cryostat sections of renal tissue from (a–c)
lama3þ /þ and (d–f) lama3/ mice were stained with antibodies
to (a, d) WT-1, (b, e) vWF, and (c, f) aSMA. (a, d) WT-1, a marker of
podocytes, is positive in both groups of animals. Glomerular
endothelial cells stain positively for vWF in both (b, e) wild-type
and mutant mice. aSMA was detected in the wall of small BVs
(arrow) in both (c) wild-type and (f) mutant mice, but only
(c) glomeruli (G) in wild-type animals contained cells that expressed
aSMA. Original magnification  400.
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a central mesangial pattern (Figure 6d and j). The transition
in staining for LAMB2 occurred normally in lama3þ /þ
mice. In the null-mutant mice, LAMB2 was detected in the
GBM, which indicates that its appearance coincides with
GEnC development. This is further supported by the
abundant staining for LAMB2 in the central zone, which
was populated with GEnC (Figure 6e and k). Collagen IV(a3)
was detected in the GBM in both mutant and wild-type mice
(Figure 6f and l). These data show that disruption of the
lama3 gene did not disturb the expression of or normal
transition in collagen IV isoforms expressed by podocytes in
the developing glomerulus.
LAMA3 and LN-5 expression in normal adult and newborn,
rat and mouse kidneys
Lama3 mRNA is expressed in whole fetal and adult mouse
kidney; however, LN-5 protein was only detected in the
arteriolar basement membranes;36 thus, LAMA3 was initially
not thought to play a role in glomerulogenesis.8,36 The
abnormalities we observed in the late stages of GEnC
development in lama3/ mice suggested that LAMA3 might
be expressed in a limited distribution in the glomerulus and
may have been missed when tissues were stained with
antibodies to LN-5. Additional studies were undertaken to
confirm the expression of the LAMA3 in normal glomeruli.
Using a variety of antibodies to LAMA3 and tissues from
newborn and adult humans, rats, and mice, we found
LAMA3 staining in an endothelial pattern. Although some
antibodies to LN-5 showed no glomerular staining, P3E4-
stained glomeruli in rat and human kidney, but not mouse
kidney (not shown). As shown in Figure 7, rabbit antibody to
LAMA3 shows faint staining in the periphery of the capillary
wall, but increased staining around the centrally oriented
nucleus of GEnC. The mesangium is unstained. Dual staining
for collagen IV(a3) and LAMA3 shows that LAMA3 is only
detected on the endothelial side of the collagen IV(a3)-
positive GBM, which suggests that it is an endothelial
product. Staining for collagen IV(a3) along the GBM can be
seen in early capillary loop stage glomeruli, when endothelial
cells are just migrating into the vascular cleft. LAMA3 was
(+/+) (–/–)
PDGF
a b
Figure 5 | Immunostaining for PDGF. Immunofluorescence staining
of (a) lama3þ /þ and (b) lama3/ for PDGF B chain. Note that in (a),
the mature glomerulus (G) stains negatively for PDGF, whereas
staining is detected in the wall of a small arteriole (arrow). (b) In
contrast, abundant staining for PDGF is detected in glomeruli
and small arterioles in samples from lama3/ mice. Original
magnification 400.
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Figure 6 | Immunostaining for LN and collagen IV(a3). (a–f) Tissues
from lama3þ /þ and (g–l) lama3/ mice were stained for (a, g) LN 1,
(b, h) LN a5, (c, i) LN g1, (d, j) LN b1, (e, k) LN b2, and (f, l) collagen
IV(a3). In each case, the glomerular landmarks are less distinct in
mutant mice than in wild-type mice in keeping with the structural
abnormalities shown above. Disruption of the lama3 gene did not
prevent expression of LN a5 in the GBM, or the late expression of
LN b2 or collagen IV(a3). Normally, LN b1 is expressed in the early
GBM and then it is replaced by LN b2. LN b1 reappears as a product
of the mesangium during the maturing capillary loop stage. The
absence of a mesangium and the GBM pattern of staining for LN b1
in the lama3/ mice suggest that LN b1 abnormally persists
or reappears in the GBM. Original magnification  400.
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not detected in developing glomeruli before the appearance
of collagen IV(a3).
The pattern of staining for LAMA3 in relation to collagen
IV(a3) suggests that LN-5 is a GEnC product. RNA from
cultured glomerular cells and glomeruli isolated from rats
and mice was analyzed for the expression of lama3, lamb3,
and lamc2 mRNA. As seen in Figure 8, all three chains of
LN-5 were found in GEnC, but not MC or GEC. In the case
of LAMA3, protein was also identified in extracts from GEnC
and whole glomeruli. Although cells do not always behave the
same in culture as they do in vivo, these studies support the
conclusion that staining shown in Figure 7 is identifying
LAMA3, and together with the staining pattern shown in
Figure 7, GEnC appear to be the most likely source of LN-5
synthesis.
DISCUSSION
These studies show that in addition to the well-recognized
skin abnormalities that occur with spontaneous mutations in
LN-5 genes,23,24 mice with targeted disruption of the lama3
gene1 develop abnormalities in maturation of GEnC and in
the development of mature MC. Complementary studies in
newborn rat kidney showed that LAMA3 protein is detected
on the endothelial side of newborn and adult glomeruli. The
appearance of LAMA3 at the early capillary loop stage
corresponds with the stage of maturation arrest in the
lama3/ mutant mice. The detection of LAMA3 in cultured
GEnC, but not MC or podocytes, suggest that this LN
isoform is predominantly a product of GEnC. The absence of
mature MC in lama3/ mice indicates a need for LAMA3
for MC migration and/or differentiation.
Previous studies, predominantly based on immuno-
staining of mouse tissues, failed to demonstrate LN-5 in
the kidney;36 thus, renal abnormalities were not initially
expected in lama3 null-mutant mice. Because we had
observed lama3 mRNA in GEnC in culture, careful evalua-
tion of the lama3 mutant was pursued. In addition to
abnormalities in glomerulogenesis in these mice, lama3
mRNA was detected in isolated mouse glomeruli by reverse
transcriptase polymerase chain reaction (RT-PCR), which
confirms the expression of this gene in vivo, but it does not
identify the cell responsible for its synthesis. Analysis of
cultured rat GEnC, and RNA and protein extracts of isolated
adult rat glomeruli complemented our findings in the mouse.
The restricted distribution of the LAMA3 protein on the
subendothelial side of the capillary wall in the glomerulus
may explain why it was missed in earlier studies. With the
recent development of LN chain-specific antibodies, LN-5
expression has been more widely recognized. LAMA3 has
been demonstrated in a variety of, but not all, endothelial
cells/BVs,37 and in agreement with our findings, Miosge
et al.38 found LAMA3 in the vascular cleft, developing GBM
and mature GBM in human kidney. Because we have also
identified lamb3 mRNA and protein in GEnC and whole
a b
Figure 7 | Staining of newborn rat kidney for LAMA3 and collagen
IV(a3). (a) Staining with rabbit antibody to LAMA3 shows an
endothelial pattern of staining. LAMA3 is also observed in glomerular
arterioles. (b) In samples that were dual stained for collagen IV(a3)
(red) and LAMA3 (green), LAMA3 is only observed on the endothelial
side of the GBM. The inset contains a higher magnification of a
portion of a loop, showing abutment of LAMA3 with the collagen
IV(a3) of the GBM on the endothelial side, and absence of staining for
LAMA3 on the epithelial side. Central areas corresponding to the
mesangium (*) are unstained. Original magnification  400.
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Figure 8 | Expression of lama3 mRNA and protein, and mRNA for
LAMB3 and LAMC2. (a) RT-PCR analysis of LAMA3 (LNa3) mRNA in
adult mouse glomeruli (lane 1), adult rat glomeruli (lane 2), and
cultured rat GEnC (lane 3). Note product of the expected size in all
three samples. Product for LAMA3 was confirmed by sequencing.
(b) Northern blot showing the typical pattern of hybridization using
a cDNA probe to mouse lama3. The expected 6 kb band is detected
in RNA from mouse keratinocytes (MEK, lane 1) and rat glomerular
endothelial cells (GEnC, lane 3). No hybridization is seen for rat
mesangial cells (MC, lane 4). A faint band is present in RNA from
podocytes (GEC, lane 2). Given the higher load of RNA in this lane, it
suggests that lama3 mRNA expression is very low in podocytes as
compared to GEnC. (c) mRNA from GEnC and MC were analyzed by
RT-PCR for LAMB3 (LNb3) and by Northern blot for LAMC2 (LNg2).
Product of the appropriate size (430 bp and 5.2 kb, respectively) was
only observed in GEnC. (d) Matrix extracts from the following samples
were examined by Western blot with antibody to LN a3. MC (lane 1),
podocytes (GEC, lane 2), GEnC (lane 3), whole glomerular extract
(WGM, lane 4), and skin (lane 5).
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glomerular extracts (data not shown), it appears that LAMA3
participates in the formation of LN-5. Additional studies are
required to determine if LN-6 or -7 are also formed.
Recently, a single case report of a child with double
mutations in the lamb3 gene exhibited severe nephrotic
syndrome. Glomeruli had abundant endothelial cells and
very small capillary lumens similar to the lama3 null mice. In
the absence of LN-5, LAMA3 was overexpressed in
glomerular capillaries in this child. This suggests that
ongoing expression of LN-6/7 was not sufficient to prevent
the development of renal abnormalities. In association with
the absence of LN-5, there was reduced glomerular expres-
sion of LAMA5, which may have also contributed to the
severity of the lesion. The reduction in LAMA5 may have
been owing to abnormalities in the development of MC,
which were not evaluated in this child. This report supports
the importance of LN-5 to kidney development. Although we
did not observe severe nephrotic syndrome in the lama3/
mice, Hata et al.39 point out that nephrotic syndrome only
became manifest after intravenous volume repletion and
enhanced glomerular filtration. As lama3 null mice lack the
ability to suckle effectively and are dehydrated, it is possible
that nephrotic syndrome would have developed had they
been supported with volume repletion.
LN-5 has been detected in renal collecting tubules and
papillary structures, as well as the ureteric bud during
nephrogenesis,40 and increased expression occurs with
ischemic acute renal failure.41 Targeted disruption of LN-5
receptors has been associated with abnormalities in tubular
development.42 Furthermore, Zent et al.40 found significant
abnormalities in branching morphogenesis and tubular
development when the LN-5 receptors were disrupted, with
much less impact on tubulogenesis when the interaction with
these integrins was blocked by antibodies to LN-5. These
authors concluded that ligands other than LN-5 were either
more important or could substitute for LN-5 in mediating
branching morphogenesis during kidney development. In
our examination of kidneys, staining for LAMA3 or LN-5 was
not detected in proximal TBM, nor were abnormalities of the
proximal tubule observed as reported in the integrin mutant
animals.42 As we did not do morphometric studies of the
medullary and papillary regions of the kidney, differences in
the degree of tubular branching may have been missed. Mild
abnormalities of podocyte foot processes have been observed
in animals that lack LN-5 receptors, yet no abnormalities in
GEnCs were reported.42 This suggests that the LAMA3 in
GBM directs endothelial cell differentiation through LN
receptors other than a3b1 and a6b4 integrins.
The pattern of staining of the LN a3 chain in glomeruli
suggests that it is primarily a product of endothelial cells in
vivo. During glomerulogenesis, matrix secreted by podocytes
and GEnC fuse to form the mature GBM.43 Although it was
once thought that only the podocytes contributed to GBM in
the adult, differential staining for collagen IV isoforms12,13
confirms that in the adult GBM continues to be a fused
product of podocytes and GEnC. Similar conclusions have
been drawn by St John and Abrahamson9 using antibodies to
LN-1 and LN-11. Our data indicate that podocytes and
GEnC also secrete distinct LN isoforms, thereby giving the
mature GBM a complex composition. Expression of LN a3
predominantly by GEnC in vitro supports this conclusion;
however, additional studies are required to exclude any
contribution by podocytes.
The present studies show that LAMA3 expression plays an
important role in glomerular endothelial development.
Although a considerable amount is known about the contri-
butions of LN to angiogenesis in vitro,44 little is known about
the factors that regulate GEnC maturation. In lama3/
mice, endothelial cells migrate into the scaffolding of GBM
laid down by the podocytes. GEnC secrete their own
basement membrane and attach to it, but they fail to form
patent tubes or fenestrae; thus, LN a3 appears to be required
for GEnC maturation. The a3 chain appears to confer an
essential function to GEnC that cannot be served by LAMA5,
as it was present in equal amounts in GBM in lama3þ /þ and
lama3/ mice.
The role of LAMA3 in MC differentiation appears to be
secondary, as MC do not express either transcript of lama3.
Recent studies27 established that MC arise by differentiation
of cells within the developing mesenchyme, where they
proliferate and migrate in response to PDGF.45 MC migrate
from the mesenchyme into developing glomeruli after
endothelial cells line the GBM produced by podocytes.
Although we could not clearly identify MC in any of the
lama3/ mice, it is possible that mesangial progenitors not
yet expressing aSMA were present. In other models of BV
development, endothelial cells synthesize and release PDGF,
which in turn stimulates proliferation of vascular smooth
muscle cells.46 The requirement of MC for PDGF has been
established by many studies.31–33,47 Abundant immunostain-
ing of PDGF B chain in lama3/ mice indicates that GEnC
matured to the stage of expressing PDGF and that lack of
PDGF is not the cause for failure of MC development. The
absence of LAMA3 may have altered the response to PDGF as
there is recent evidence showing that LN-5 retention of
PDGF is required to create a directional gradient drawing
pericytes to endothelial cells and allowing close investment of
the developing capillary.48 This may have contributed to the
lack of MC in the glomerulus.
The lack of development of MC in the lama3 null mice
may also have contributed to failure of complete maturation
of endothelial cells. Pericyte contact with growing endothelial
cells suppresses proliferation, decreases PDGF expression,
and facilitates differentiation of endothelial cells.34,49 As in
other developing BVs, the intimate interaction between
endothelial cells and MC may be required for completion
of the differentiation program of both cells. Our results add
to the growing evidence that temporal and spatial expression
of specific LN isoforms are critical to glomerular differentia-
tion and maintenance of the mature phenotype.3,19,50
Furthermore, they suggest that the LAMA3 plays a critical
role in the development of this specialized vascular structure.
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MATERIALS AND METHODS
Materials
Antibodies to various proteins were as follows: monoclonal antibody
to WT-1 (Santa Cruz BioTech, Santa Cruz, CA, USA);26 anti-a-SMA
(Sigma-Aldrich, St Louis, MO, USA);28 vWF (DAKO, Carpenteria
CA, USA); rabbit anti-PDGF peptide (aa 101–116 from human
PDGF B chain) (Calbiochem, La Jolla, CA, USA); monoclonal anti-
collagen IV (a3) (M2) (SciMedix Denville, NY, USA);51 anti-LN-1,52
polyclonal rabbit anti-recombinant LAMB2 fusion protein (aa
1608–1727), and anti-LAMA3 fusion protein (corresponding to aa
1458–-1723) were prepared and characterized in our laboratory;
mouse monoclonal antibody to rat LAMA3 (5C5) isolated from rat
804G cells was kindly provided by Dr Jonathan Jones (Northwestern
University, Chicago, IL, USA);53 rabbit antibody to LAMA3 kindly
provided by Dr Rupert Timpl (no. 1125); monoclonal antibody to
LN-5 from human keratinocytes (Clone P3E4, Chemicon, Temecula,
CA, USA); rabbit antibody to recombinant LAMA5 was provided by
Dr Jeffery Miner (Washington University, St Louis, MO, USA);15
monoclonal rat anti-mouse LAMB1 (5A2) was provided by Dr Dale
Abrahamson (University of Kansas Medical Center, Kansas City, KS,
USA);27 and monoclonal mouse anti-rat LN g1 (LAMC1) (D18),
originally characterized by Dr Joshua Sanes,54 was obtained from
the Developmental Studies Hybridoma Bank (Bethesda, MD, USA).
Secondary antibodies included fluorescein isothiocyanate-conju-
gated, species-specific anti-immunoglobulinG (Jackson Labora-
tories, Westgrove, PA, USA). A cDNA probe to lama3 has been
described previously.55
Animal model
A 1.2 kb genomic fragment containing the murine equivalent of
exon A3 for the lama3 gene was replaced with a neo-cassette driven
by the phosphogluco kinase promoter as described.1 After electro-
poration into embryonic stem cells, colonies were screened for
homologous recombination.1,32 Tissue culture and blastocyst
injections were by routine methods.55 Both the a3a and a3b
transcripts of LN a3 were disrupted in this animal, as exon A3 is
common to both.55 Mice heterozygous for the lama3 mutation were
crossed to yield homozygous null offspring. Twenty-five percent of
offspring were homozygous null as determined by PCR analysis.1
Tissues from three different litters were examined, including six
normal and lama3þ /þ mice, and six lama3/ mice. Lama3/
mice exhibit severe blistering skin lesions, and are killed by the dam
if they are not removed to a separate cage. Mutant mice are unable
to suckle and become severely dehydrated. To avoid confounding the
structural analysis, pups were surgically removed at the onset of
labor or killed just after birth.
Cell culture
Rat glomerular MC were prepared by modification56 of routine
methods.57 Rat podocytes and GEnC were isolated, characterized,
and cultured as described previously.58 For preparation of matrix
extracts, cells were grown to confluency under standard conditions
and the matrix extracted.59 Mouse epidermal keratinocytes were
prepared as described.1
Northern blots and RT-PCR
Total RNA was extracted from mouse epidermal keratinocyte,
cultured rat podocytes, GEnC, MC, and whole glomeruli by routine
methods.59 Glomeruli were isolated from adult rats and mice by
sieving as described.60 Total RNA (10–20mg) was separated by
electrophoresis on a 1% agarose denaturing gel, transferred to
nitrocellulose, and fixed with a StrataGene Stratalinker.59 Hybridiza-
tion was performed using a cDNA probe to mouse lama3
(NA4036–5204).61 The blot was washed three times in 0.3 M NaCl,
0.03 M sodium citrate and 0.1% sodium dodecyl sulfate at 421C for
10 min and 561C for 25 min. For detection of mRNA for lamc2, a
cDNA probe corresponding to mouse lamc2 (NA748–1340) was used.
RNA yields from isolated mouse glomeruli were insufficient for
Northern blot analysis; thus, lama3 mRNA was detected by RT-PCR.
RNA from adult rat glomeruli and rat GEnC and MC were included
as controls. We used the following primers: sense, 50-TCCCAT
GAGGTTCAATGGTAAA (NA2398–2419) and antisense, 50-GATC
CAAATTAAGGAGCGTGTT (NA2807–2828). The RT reaction was
performed with random hexamers and murine leukemia virus
reverse transcriptase (Perkin Elmer, Foster City, PA, USA) at 421C
for 15 min, 991C for 5 min, and 51C for 5 min. Amplification was
carried out using the a3 primers and HotStarTag (Qiagen, Valencia,
CA, USA) for 30 cycles at 951C for 15 min, 941C for 30 s, 531C for
1 min, 721C for 1 min, and 721C for 7 min. The product (430 bp)
was confirmed to represent lama3 by dyedeoxy sequencing (PE
Biosystem, Foster City, CA, USA). Primers for lamb3 were as
follows: sense, 50-GTGCTATCCCAGACCAAACA (NA2986–3005)
and antisense, 50-CCGGTCCTTCAACTCTGTAT (NA3398–3417).
Western blot
Samples of cultured cell layers were solubilized as described
previously.59 Extracts of whole glomerular matrix were prepared
similarly, with the exception that isolated glomeruli were sonicated
before overnight incubation in phosphate-buffered saline containing
0.05% Triton X-100, 0.025 M ethylenediaminetetraacetic acid, 0.1 M N-
ethylmalemide, 2 mM phenylmethylsulfonyl fluoride, and 0.02 mg/ml
pepstatin. Electrophoresis was performed under reducing conditions
in 5% sodium dodecyl sulfate-polyacrylamide gel containing urea
followed by transfer to nitrocellulose.62 Immunoblotting was
performed using a chemiluminescent substrate, SuperSignal (Pierce,
Rockford, IL, USA), according to the manufacturer’s instructions.
Tissue analysis
Shortly after birth, renal tissues from wild-type and mutant mice
were harvested. Tissues were snap-frozen in pre-cooled isopentane
for immunofluorescence microscopy52 or fixed in 2.5% glutaralde-
hyde in cacodylate buffer for routine electron microscopy. Tissues
were also prepared from normal newborn mice, and normal
newborn and adult rat kidney.
Fluorescence microscopy
Kidneys from wild-type and mutant mice were stained for WT-1,
aSMA, vWF, PDGF, LN-1, LN chains a5, b1, b2, and g1, and
collagen IV (a3). Adult and newborn, rat and mouse kidney tissues
were stained for LAMA3 and LN-5. Tissues were cryostat sectioned
at 4mm, fixed in acetone, stained with primary antibody for 20 min
at room temperature, rinsed 3 with phosphate-buffered saline,
and stained with secondary antibody for all of the antibodies, except
anti-LN b2.52 Before incubation with antibody to LAMB2 overnight,
tissues were fixed with 4% paraformaldehyde. All slides were
mounted in Fluormount and observed with a Leitz microscope
equipped with epi-illumination. The fluorescent images were
recorded on Kodak DX 400 black and white film or with a Spot
RT color digital camera (Diagnostic Instruments Inc., Sterling
Heights, MI, USA).
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Electron microscopy
Kidneys were harvested, diced into 1 mm squares, and fixed in
2% gluteraldehyde in cacodylate buffer for 2 h at 41C, treated
with 1% osmium tetroxide for 30 min at room temperature,
and washed three times with cacodylate buffer. They were
sequentially dehydrated through ascending concentrations
of alcohol (35–100%) to resin, and partially polymerized at
room temperature overnight. A Sorvall MT6000 ultramicrotome
was used for sectioning and specimens were examined on a JEOL
TEM S100.
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